Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02427451
Brief Title: Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or Previously Untreated Chronic Lymphocytic Leukemia

First Submitted : March 4, 2015
First Submitted that Met QC Criteria : April 24, 2015
First Posted : April 28, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : November 4, 2019
Last Update Posted : November 6, 2019